📈 Stocks
ALK-Abelló Reports Positive Phase 3 Results for ACARIZAX in China
(5 days ago)
ALK-Abelló's ACARIZAX trial in China hits primary efficacy targets, strengthening the company's expansion strategy in partnership with GenSci to address a massive,…